AQUA Therapeutics

About:

AQUA Therapeutics engages in the development of therapeutic drugs for the treatment of fibrotic diseases.

Website: http://www.aqua-therapeutics.com

Top Investors: Mitsubishi UFJ Capital, SMBC Venture Capital, Nissay Capital, Innovation Network Corporation of Japan

Description:

AQUA Therapeutics primarily engages in the development of therapeutic drugs for the treatment of fibrotic diseases. It aims to develop medicine using oligonucleotide-based therapeutics as a drug development platform. It also engages in the research and development, manufacturing, and sales of pharmaceuticals, non-medicinal products, and cosmetics, medical research consultancy, and the development of medical devices, instruments, and equipment. AQUA Therapeutics was founded in 2012.

Total Funding Amount:

950M JPY

Headquarters Location:

Hyogo, Hokkaido, Japan

Founded Date:

2012-03-19

Contact Email:

support(AT)aqua-therapeutics.com

Founders:

Kazunori Yoshikawa

Number of Employees:

1-10

Last Funding Date:

2015-09-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai